CareerPlanSign in

Senior Director, Disease Biology

Headquarters - 3181 Porter Drive, Palo Alto, CA💼 Full-time💰 $263,500–$263,500🗓 2026-08-31 → 2026-09-26

Core

Lead target discovery and preclinical development for the Alzheimer's Disease Initiative, building new teams and workflows to carry validated targets through hit-to-lead progression and IND enabling studies.

Role type

Senior Director, Disease Biology (Strategy & Team Building)

Builds

New target discovery and preclinical development teams and workflows for Alzheimer's disease drug candidates

Domain

Biotechnology / Neurodegenerative Disease / Drug Discovery

Deliverable

production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work

Required skills

Target discovery strategy, Preclinical program management, Team building and mentoring, Cross-functional program leadership, CRO and external partner management, Portfolio prioritization

Preferred skills

Alzheimer's disease drug discovery experience, Animal model generation and validation (APOE4, TREM2), Computational biology and machine learning integration, High throughput biology partnership

Technologies

Causal modeling, Human genetic data analysis, 3D cellular models, In vivo and in vitro disease models

Responsibilities

Build a new team to carry validated targets through drug discovery into preclinical programs; Guide programs through lead optimization and generate proof of concept data; Lead target discovery translating genetic and functional genomics findings into therapeutic targets; Lead existing in vivo and in vitro discovery teams; Partner with computational teams to apply causal modeling and prioritize candidates; Align priorities across target discovery and preclinical teams; Manage CRO and external partner relationships; Represent discovery strategy in cross-functional reviews

Seniority

Senior Director, hands-on IC with strategic leadership

Sourced via greenhouse · Listed on CareerPlan, which tracks 70,000+ jobs from 20+ sources.